Botulism, a food-borne toxin-mediated disease caused by Clostridium botulinum is still a common disease, which is most frequent in the rural environment; 108 cases, 66 males and 42 females, average age 32 years, were recorded from 1965 to 1990 in the infectious disease department of the University Hospital of Poitiers (France). In 83 % of patients, the food responsible was home-cured ham. Mean incubation time was 3-4 days; digestive symptoms were observed in 93% of cases, ocular symptoms in 92% and urinary tract dysfunction in 22 %. A scale of severity was used to classify the patients into those suffering from severe (6), intermediate (50) and mild (52) forms of the disease. Botulinum toxin type B was found in 36 (52 %) of 69 blood samples and in 41 (51 %) of 81 samples of the suspected food. From 1965 to 1976, 44 patients were treated with both toxoid and heterologous equine serotherapy. Since 1976, 29 patients have been treated with guanidine hydrochloride (35 mg/kg daily) and 35 patients with guanidine hydrochloride plus heterologous serotherapy. All 108 patients recovered without any sequelae.
Centers for Diseases Control Botulism in the United States 1897-1973. Handbook for epidemiologists, clinicians and laboratory workers Atlanta: CDC; 1974
MorrisJG,
SnyderJD,
WilsonR,
FeldmanRA.
Infant botulism in the United States: an epidemiological study of cases occurring outside of California. Am J Public Health1983; 73:1385–1388
HorwitzMA,
HughesJM,
MersonMH,
GangarosaEJ.
From the Center for Disease Control. Food-borne botulism in the United States. 1970–1975J Infect Dis1977; 136:153–159
LundBM,
GrahamAF,
GeorgeSM.
Growth and formation of toxin by Clostridium botulinum in peeled inoculated vacuum-packed potatoes after a double pasteurization and storage at 25°C. J Appl Bacteriol1988; 64:241–246
FourrierA,
DelmerM,
WattelF,
FuronD,
MoutonY.
Cas récents de botulisme dans le nord de la France. A propos de 26 observations (1962-1971). Rev Med1972; 40:2615–2627
HughesJM,
BlumenthalJR,
MersonMH,
LombardGL,
DowellVR,
GangarosaEJ.
Clinical features of types A and B food-borne botulism. Ann Intern Med1981; 95:442–45
DezfulianM,
HathewayCL,
YolkenRH,
BarlettJG.
Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism. J Clin Microbiol1984; 20:379–383
DavisLE,
JohnsonJK,
BicknellJM,
LevyH,
McEvoyKM.
Human Type A botulism and treatment with 3,4-diaminopyridine. Electromyogr Clin Neurophysiol1992; 32:379–383
HorwitzMA,
HathewayCL,
DowellVR.
Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient. A method for selectively removing interfering substances from clinical specimens. Am J Clin Pathol1976; 66:737–742
DowellVR,
McCroskeyLM,
HathewayCL,
LombardCL,
HughesJM,
MersonMH.
Coproexamination for botulinal toxin and Clostridium botulinum. A new procedure for laboratory diagnosis of botulism. JAMA1977; 238:1829–1832
MacDonaldKL,
SpenglerRF,
HathewayCL,
HargettNT,
CohenML.
Type A botulism from sauteed onions. Clinical and epidemiologic observations. JAMA1985; 253:1275–1278
HathewayCH,
SnyderJD,
SealsJE,
EdellTA,
LewisGE.
Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B and E. J Infect Dis1984; 150:407–412
RobineauM,
ModaiJ,
LaffayJ,
DomartA.
Note preliminaire sur le traitement du botulisme par la guanidine. A propos d'un cas. Presse Med1971; 79:1169–1171